Synergic effect of prostacyclin (PGI2) and alpha-blocking-agent on adrenalin-induced human platelet aggregation.
D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology*; D004357:Drug Synergism; D011464:Epoprostenol / Q000494:pharmacology*; D006801:Humans; D009530:Nicergoline / Q000494:pharmacology; D010974:Platelet Aggregation / Q000187:drug effects*; D011453:Prostaglandins / Q000494:pharmacology*
D000317:Adrenergic alpha-Antagonists; D011453:Prostaglandins; D011464:Epoprostenol; D009530:Nicergoline